)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Labcorp
Labcorp (LH) investor relations material
Labcorp Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary28 Oct, 2026
Executive summary
Q3 revenue was $3.810B, up 6.9% reported and 7.0% at constant currency; adjusted EPS rose 14.5% to $4.78.
Adjusted operating margin expanded to 15.0% from 14.4%; FY26 revenue and adjusted EPS guidance increased.
Financial highlights
GAAP net earnings attributable to shareholders were $262.8M vs. $261.1M; diluted EPS was $3.22 vs. $3.12.
Adjusted net income was $390.3M vs. $349.8M; adjusted operating income was $570.0M vs. $513.3M.
Operating cash flow was $563.8M and free cash flow was $412.2M; free cash flow rose from $281M, primarily on improved working capital, partly offset by higher planned capex.
Nine-month revenue was $11.079B vs. $10.436B; adjusted net income was $1.152B vs. $1.038B, and adjusted EPS was $14.02 vs. $12.37.
Reported operating income was $402.1M vs. $396.6M; reported operating margin declined 60 bps to 10.6%.
Outlook and guidance
FY26 enterprise revenue guidance increased to $14.779B–$14.887B, or 5.9%–6.7% growth, from $14.710B–$14.827B; midpoint growth rose 50 bps.
Adjusted EPS guidance increased to $18.30–$18.70 from $18.10–$18.55; midpoint increased $0.18.
Diagnostics revenue guidance is $11.475B–$11.551B, or 5.5%–6.2% growth; Biopharma guidance is $3.328B–$3.358B, or 7.4%–8.4%.
FY26 free cash flow guidance remains $1.24B–$1.36B; capex is expected to be nearly 4% of revenue and the adjusted tax rate nearly 23%.
Enterprise margin expansion is expected in FY26, with LaunchPad on track for $125M in full-year savings.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Labcorp
- Reaffirmed strong growth outlook, driven by specialty testing, tech, and strategic acquisitions.LH
Morgan Stanley 24th Annual Global Healthcare Conference - Specialty diagnostics, innovation, and disciplined capital deployment drive strong growth.LHInvestor Day 2026
- Q2 2026 revenue rose 5.8% to $3.73B, with adjusted EPS up 14.9% and raised full-year guidance.LHQ2 2026
- Q1 momentum, specialty testing, and AI-driven innovation fuel growth and strategic expansion.LHJefferies Global Healthcare Conference 2026
- All agenda items passed, with management highlighting financial strength and addressing supply chain risks.LHAGM 2026
- Q1 2026 delivered 5.8% revenue growth, higher margins, and raised guidance for the full year.LHQ1 2026
- 2025 saw record revenues, board refreshment, and strong ESG and pay-for-performance alignment.LHProxy filing
- Vote on directors, executive pay, and auditor at the May 2026 Annual Meeting.LHProxy filing
- Q2 2025 revenue up 9.5% to $3.53B, with double-digit growth and raised full-year guidance.LHQ2 2025
Next Labcorp earnings date
Q4 202616 Feb, 2027
Labcorp
Next Labcorp earnings date
Q4 202616 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company offers a range of tests in its human diagnostic division, which is operated under the name of LabCorp. The Division provides testing and analytical services to the clients in health care industry, pharmaceutical companies, manufacturers, academic institutions and government agencies. Its offerings include anatomic pathology services, such as fine needle aspiration cytology (FNAC), cancer genetics/genomics, oncology focused protein marker testing, genetic counseling, and targeted genomic medicine; clinical chemistry test such as quantitative immunoassays and traditional immunoassays for the detection of infectious diseases; molecular diagnostics; microbiology - includes products for culture identification and antimicrobial sensitivity determination for transplant recipients and suspected infectious disease patients. In addition, the announced plans to acquire Knight Diagnostic Laboratories from New Jersey based Knight Human Capital Management. Laboratory Corporation of America Holdingsin is based in Burlington, North Carolina.